Johns Hopkins Announces New Clinical Trial For Post-Treatment Lyme Disease Using Psilocybin
Johns Hopkins Center for Psychedelic and Consciousness Research (CPCR) is embarking on a new clinical trial for individuals with Post-Treatment…
Gisèle Wertheim Aymes1 August 2022










![women [longevity live]](https://longevitylive.com/wp-content/uploads/2020/01/photo-of-women-walking-down-the-street-1116984-100x100.jpg)






